◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Okasan Securities Group Inc. (8609) EPS 2022–2026
DATA UPDATED 2026-08-09
Okasan Securities Group Inc. annual earnings per share (EPS) for fiscal 2026 was JPY 106.48, an increase of 66.2% from JPY 64.08 in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
8609 Annual EPS
| EPS (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|
| Diluted EPS | JPY 106M | — | JPY 64M | JPY 3M | JPY 51M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
8609 Quarterly EPS
| EPS (quarterly) | 2026-06-30 | 2025-06-30 |
|---|
| Diluted EPS | JPY 40M | JPY 9M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
EPS at Comparable Companies
- 8601 EPS — Daiwa Securities Group Inc.
- 6030 EPS — CITIC Securities Company Limited
- 8628 EPS — Matsui Securities Co., Ltd.
- 2611 EPS — Guotai Haitong Securities Co., Ltd.
- 8616 EPS — Tokai Tokyo Financial Holdings, Inc.
- 2127 EPS — Nihon M&A Center Holdings Inc.
More 8609 metrics: Revenue · Net Income · Free Cash Flow
All 8609 financial statements → Interactive 8609 charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.